QualityStocksNewsBreaks – BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) Continues to Advance Promising BriaCell Clinical Program
During 2018, BriaCell Therapeutics (OTC: BCTXF) (TSX.V: BCT) has attained topline safety and efficacy clinical data in a clinical trial,…